Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotalol for Arrhythmia in Children
NCT03895411Phase 4Unknown
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sotalol in paroxysmal supraventricular tachycardia (PSVT), Paroxysmal Atrial Tachycardia (PAT), ventricular tachycardia (VT) and 2 more (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoint: QT interval of ECG at 3 months. Status: unknown.
02
Drugs
sotalol
03
Conditions
paroxysmal supraventricular tachycardia (PSVT)Paroxysmal Atrial Tachycardia (PAT)ventricular tachycardia (VT)Idiopathic Ventricular Tachycardia (IVT)Premature ventricular contraction (PVC)
Beyond the preview
Go deeper on NCT03895411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03895411.